摘要
目的:探讨大鼠变应性鼻炎制模基础致敏阶段,给予CpGDNA(CpG1826)腹腔注射对其鼻黏膜EOTAXIN表达的影响作用。方法:在大鼠变应性鼻炎基础致敏阶段,腹腔注射卵清蛋白和氢氧化铝佐剂的同时,给予CpGDNA腹腔注射,观察其对模型形成的影响。观测指标包括症状得分、鼻黏膜局部嗜酸粒细胞表达以及鼻黏膜局部EOTAXIN表达情况。结果:CpGDNA应用后,变应性鼻炎模型症状减轻,鼻黏膜局部及骨髓中嗜酸粒细胞减少,鼻黏膜中EOTAXIN表达降低。结论:CpGDNA在基础致敏阶段应用对大鼠变应性鼻炎模型形成具有显著的干扰作用,其对鼻黏膜EOTAXIN表达的抑制可能为其作用机制之一。
Objective: To investigate the effect of CpG DNA applied intraperitoneally on the expression of EOTAXIN of allergic rhinitis model. Method:CpG DNA was injected intraperitoneally to rat at the same time of the basic intraperitoneal immunized. The symptoms, expression of eosin6phil(EOS) in nasal cavity and expression of EOTAXIN in the nasal mucosa were measured. Result: After the CpG DNA was applied, the symptom scores, eosinophil(EOS) in nasal cavity and expression of EOTAXIN were weaken. Conclusion:There was great reverse effect of CpG DNA on the foundation of rat model of experimental allergic rhinitis,suppression of EOTAXIN may be one of the mechanisms.
出处
《临床耳鼻咽喉科杂志》
CAS
CSCD
北大核心
2006年第8期362-364,共3页
Journal of Clinical Otorhinolaryngology